| Nucleotide mix |
| Motor (50 - 100 µM; purity > 95%) |
| 0.5 M Tris-OAc, pH 7.5 |
| 10 mM EGTA |
| 10 mM MgCl2 |
| DDW |
| Sephadex G-50 Medium column (0.8 cm in x 20 cm) |
| Column buffer = | 50 mM Tris-OAc, pH 7.5 1 mM EGTA 1 mM MgCl2 |
| Scintillation fluid |
| Scintillation vials and disposable inserts |
| 1. | Prepare reaction mixes (mutant and wild-type) by mixing the following: |
__ µL 1 µL 10 µL 10 µL 10 µL __ µL ______ 100 µL | 50 - 100 µM motor gamma or alpha-32PATP nucleotide mix 0.5 M Tris-OAc, pH 7.5 10 mM EGTA 10 mM MgCl2 DDW |
Adjust the volume of the motor to give 5 - 10 µM in the mix and adjust the volume of DDW to give the final volume of 100 µL. Centrifuge the motor before adding to the mix. Incubate the mix on ice overnight. Prepare reaction mixes for both mutant and wild-type motors on the same day. |
| 2. | Apply reaction mix to a Sephadex G-50 Medium column. |
| 3. | Collect two 1 mL fractions and label them fr 1 and fr 2, then collect 28 x 5-drop fractions (each = ~250 µL) and label them fr 3 - fr 30. |
| 4. | Take 50 µL of fractions 3 - 22 and mix with 0.5 mL of scintillation fluid in a disposable insert. Put insert into a scintillation vial, precounted to determine background of less than 30 cpm, then count the vial on the32P channel. |
| 5. | Determine protein concentration of each fraction by adding 50 µL of concentrated Bio-Rad reagent to the remainder of fractions 3 - 12 (~200 µL). Prepare a blank by adding 50 µL of concentrated Bio-Rad reagent to 200 µL of column buffer. Read each fraction in a microcuvette at OD595. Cuvette can be rinsed out with DDW between each reading. |
| 6. | Plot fraction number versus cpm and OD595. |
| 1. | For Km determination, the concentration (µM) of bound and unbound alpha-32PATP can be determined from the starting ATP concentration. |
| 2. | Co-elution of cpm with the protein peak is interpreted as bound ADP, and unbound cpm is ATP + ADP + Pi. |
Modified from Song and Endow 1998 Nature 396, 587-590.
If you use methods from the Kinesin site, we ask that you cite the Kinesin Home Page and authors, or the appropriate source publication in your work.
将 AssayMAP 的使用范围扩展至法规监管环境2022年11月28日,北京——安捷伦科技有限公司(纽约证交所:A)近日宣布推出AssayMAPBravo蛋白质样品前处理Work......
艾美捷AssayGenie GeniePlex鼠标Th1/Th2/Th177-Plex(96次测试):名称: 精灵小鼠 Th1/Th2/Th177 重套件编号:......
艾美捷AssayGenie 大鼠神经发现阵列(19个靶点):型号: SARB0105大小: 2、4 或 8检测到的物种: 鼠检测到的目标数量......
艾美捷AssayGenie 重组犬IL-6:货号 KPRT0060类型 重组蛋白数量 5微克物种 犬目标 IL-6别名 IL6;B......
艾美捷AssayGenie重组人干扰素β:货号 KPRT0629类型 重组蛋白数量 5微克物种 人目标 IFN 测试版别名 IFN......
艾美捷AssayGenie人生长因子阵列(41个靶点):型号: SARB0045大小: 2、4 或 8检测到的物种: 人检测到的目标数量: ......
艾美捷AssayGenie人类DNA损伤反应阵列(27个靶点):型号: SARB0106大小: 2、4 或 8检测到的物种: 人检测到的目标数量:&n......
酪氨酸-蛋白磷酸酶非受体2型,又称T细胞蛋白-酪氨酸磷酸酶、PTPN2和PTPT,是一种细胞质蛋白,属于蛋白-酪氨酸磷酸酶家族和非受体1类亚科。蛋白酪氨酸磷酸酶(PTP)家族的成员共享一个高度保守的催......
Sialomucin 核心蛋白 24 也称为 endolyn 或 CD164(分化簇 164)是一种由人 CD80+&n......
MycoGenie 支原体消除试剂盒旨在从受污染的细胞培养基和血清中消除支原体。 与用于治疗支原体污染的传统抗生素不同,该试剂盒通过破坏膜结构来去除支原体,甚至可以消除抗生素耐药支......